secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2021-10-18T23:59:59+00:00
Accession:  0001140361-21-034761
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics adds former Momenta CFO/CO Young T. Kwon to Board
----------------------------------------------------------------

- Dr. Kwon appointed as Class II director with term through 2024 annual meeting.
- Previously served as CFO/CO at Momenta, leading its $6.5B sale to Johnson & Johnson in 2020.
- Will receive an initial grant of options to purchase 93,500 shares of common stock.
- Currently an operating partner at Lightstone Ventures, assisting with deal sourcing and portfolio management.
- Brings over a decade of strategic, financial, and business development experience in biotech.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036121034761/0001140361-21-034761-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036121034761/brhc10029850_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-034761

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer